Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases.

Bareau B, Rey J, Hamidou M, Donadieu J, Morcet J, Reman O, Schleinitz N, Tournilhac O, Roussel M, Fest T, Lamy T.

Haematologica. 2010 Sep;95(9):1534-41. doi: 10.3324/haematol.2009.018481. Epub 2010 Apr 7.

2.

Large granular lymphocyte leukemia: natural history and response to treatment.

Fortune AF, Kelly K, Sargent J, O'Brien D, Quinn F, Chadwick N, Flynn C, Conneally E, Browne P, Crotty GM, Thornton P, Vandenberghe E.

Leuk Lymphoma. 2010 May;51(5):839-45. doi: 10.3109/10428191003706947.

PMID:
20367569
3.

Rapid and durable molecular response of refractory T-cell large granular lymphocyte leukemia after alemtuzumab treatment.

Monjanel H, Hourioux C, Arbion F, Colombat P, Lissandre S, Regner MP, Senecal D.

Leuk Res. 2010 Aug;34(8):e197-9. doi: 10.1016/j.leukres.2010.01.019. Epub 2010 Mar 7. No abstract available.

PMID:
20211489
4.

Long-term safety and efficacy of cyclosporin A therapy for T-cell large granular lymphocyte leukemia.

Pawarode A, Wallace PK, Ford LA, Barcos M, Baer MR.

Leuk Lymphoma. 2010 Feb;51(2):338-41. doi: 10.3109/10428190903470851. No abstract available.

PMID:
20038217
5.

Platelet-derived growth factor mediates survival of leukemic large granular lymphocytes via an autocrine regulatory pathway.

Yang J, Liu X, Nyland SB, Zhang R, Ryland LK, Broeg K, Baab KT, Jarbadan NR, Irby R, Loughran TP Jr.

Blood. 2010 Jan 7;115(1):51-60. doi: 10.1182/blood-2009-06-223719. Epub 2009 Oct 30.

6.

Phase II study of alemtuzumab in combination with pentostatin in patients with T-cell neoplasms.

Ravandi F, Aribi A, O'Brien S, Faderl S, Jones D, Ferrajoli A, Huang X, York S, Pierce S, Wierda W, Kontoyiannis D, Verstovsek S, Pro B, Fayad L, Keating M, Kantarjian H.

J Clin Oncol. 2009 Nov 10;27(32):5425-30. doi: 10.1200/JCO.2009.22.6688. Epub 2009 Oct 5.

7.

Interleukin-15 enhances proteasomal degradation of bid in normal lymphocytes: implications for large granular lymphocyte leukemias.

Hodge DL, Yang J, Buschman MD, Schaughency PM, Dang H, Bere W, Yang Y, Savan R, Subleski JJ, Yin XM, Loughran TP Jr, Young HA.

Cancer Res. 2009 May 1;69(9):3986-94. doi: 10.1158/0008-5472.CAN-08-3735. Epub 2009 Apr 14.

8.

T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience.

Sretenovic A, Antic D, Jankovic S, Gotic M, Perunicic-Jovanovic M, Jakovic L, Mihaljevic B.

Med Oncol. 2010 Jun;27(2):286-90. doi: 10.1007/s12032-009-9206-z. Epub 2009 Mar 21.

PMID:
19306076
9.

A critical role for DAP10 and DAP12 in CD8+ T cell-mediated tissue damage in large granular lymphocyte leukemia.

Chen X, Bai F, Sokol L, Zhou J, Ren A, Painter JS, Liu J, Sallman DA, Chen YA, Yoder JA, Djeu JY, Loughran TP, Epling-Burnette PK, Wei S.

Blood. 2009 Apr 2;113(14):3226-34. doi: 10.1182/blood-2008-07-168245. Epub 2008 Dec 15.

10.

Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia.

Mohan SR, Maciejewski JP.

Curr Opin Hematol. 2009 Jan;16(1):27-34. doi: 10.1097/MOH.0b013e32831c8407. Review.

PMID:
19057202
11.

Network model of survival signaling in large granular lymphocyte leukemia.

Zhang R, Shah MV, Yang J, Nyland SB, Liu X, Yun JK, Albert R, Loughran TP Jr.

Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16308-13. doi: 10.1073/pnas.0806447105. Epub 2008 Oct 13.

12.

Clinical improvement by farnesyltransferase inhibition in NK large granular lymphocyte leukemia associated with imbalanced NK receptor signaling.

Epling-Burnette PK, Sokol L, Chen X, Bai F, Zhou J, Blaskovich MA, Zou J, Painter JS, Edwards TD, Moscinski L, Yoder JA, Djeu JY, Sebti S, Loughran TP Jr, Wei S.

Blood. 2008 Dec 1;112(12):4694-8. doi: 10.1182/blood-2008-02-136382. Epub 2008 Sep 12.

13.

Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.

Fujishima N, Sawada K, Hirokawa M, Oshimi K, Sugimoto K, Matsuda A, Teramura M, Karasawa M, Arai A, Yonemura Y, Nakao S, Urabe A, Omine M, Ozawa K; PRCA Collaborative Study Group.

Haematologica. 2008 Oct;93(10):1555-9. doi: 10.3324/haematol.12871. Epub 2008 Jul 18.

14.

Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia.

Subbiah V, Viny AD, Rosenblatt S, Pohlman B, Lichtin A, Maciejewski JP.

Exp Hematol. 2008 Sep;36(9):1078-83. doi: 10.1016/j.exphem.2008.04.005. Epub 2008 Jun 11.

15.

Molecular profiling of LGL leukemia reveals role of sphingolipid signaling in survival of cytotoxic lymphocytes.

Shah MV, Zhang R, Irby R, Kothapalli R, Liu X, Arrington T, Frank B, Lee NH, Loughran TP Jr.

Blood. 2008 Aug 1;112(3):770-81. doi: 10.1182/blood-2007-11-121871. Epub 2008 May 13.

16.

T-cell large granular lymphocytic leukaemia: successful response to 2-deoxycoformycin.

Dincol G, Diz-Kuçukkaya R, Bicakci E.

Neth J Med. 2008 Feb;66(2):85-7.

17.

Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia.

Yang J, Epling-Burnette PK, Painter JS, Zou J, Bai F, Wei S, Loughran TP Jr.

Blood. 2008 Feb 1;111(3):1610-6. Epub 2007 Nov 9.

18.

Clinical spectrum of gammadelta+ T cell LGL leukemia: analysis of 20 cases.

Bourgault-Rouxel AS, Loughran TP Jr, Zambello R, Epling-Burnette PK, Semenzato G, Donadieu J, Amiot L, Fest T, Lamy T.

Leuk Res. 2008 Jan;32(1):45-8. Epub 2007 Jun 1.

PMID:
17544120
19.

Fludarabine, mitoxantrone and dexamethasone as first-line treatment for T-cell large granular lymphocyte leukemia.

Tse E, Chan JC, Pang A, Au WY, Leung AY, Lam CC, Kwong YL.

Leukemia. 2007 Oct;21(10):2225-6. Epub 2007 May 24. No abstract available. Erratum in: Leukemia. 2007 Dec;21(12):2577.

PMID:
17525720
20.

T-cell large granular leukemia and related proliferations.

O'Malley DP.

Am J Clin Pathol. 2007 Jun;127(6):850-9. Review.

PMID:
17509982

Supplemental Content

Support Center